Research Topics
| K J HarjaiSummaryAffiliation: Guthrie Research Institute Country: USA Publications
| Collaborators
|
Detail Information
Publications
Developing a new hybrid revascularization program: a road map for hospital managers and physician leadersKishore J Harjai
Guthrie Clinic, Sayre, Pennsylvania 18840, USA
J Interv Cardiol 25:557-64. 2012..In this article, we describe the people-process-technology issues that managers and leaders are likely to encounter as they develop a hybrid revascularization program in their practice...
Early readmissions after percutaneous coronary intervention in a rural tertiary care center (from the Guthrie Health Off-label Stent [GHOST] Registry)Kishore J Harjai
Guthrie Clinic and Robert Packer Hospital, Sayre, PA, USA
Am J Cardiol 110:491-7. 2012..2, 95% confidence interval 1.8 to 2.8). In conclusion, readmission within 30 days after PCI is common and frequently related to cardiac causes. Patients who require an ER after PCI have higher 1-year mortality and MACEs...
Long-term safety and effectiveness of drug-eluting stents compared to bare metal stents following successful PCI in non-ST-elevation myocardial infarction: findings from the Guthrie Health Off-Label StenT (GHOST) RegistryKishore J Harjai
Guthrie Clinic, Sayre, Pennsylvania, USA
J Interv Cardiol 25:28-36. 2012..The long-term safety and effectiveness of drug-eluting stents (DES) versus bare metal stents (BMS) in non-ST-segment elevation myocardial infarction (NSTEMI) beyond 2 years after percutaneous coronary intervention (PCI) is unknown...
Usefulness of routine unfractionated heparin infusion following primary percutaneous coronary intervention for acute myocardial infarction in patients not receiving glycoprotein IIb/IIIa inhibitorsKishore J Harjai
Guthrie Clinic, Sayre, Pennsylvania, USA
Am J Cardiol 99:202-7. 2007..However, in a subset of patients treated with PTCA, postprocedural heparin use was independently associated with fewer in-hospital and 1-year MACEs...
Impact of interventionalist volume, experience, and board certification on coronary angioplasty outcomes in the era of stentingKishore J Harjai
Cardiac Catheterization Laboratories, Guthrie Clinic, One Guthrie Square, Sayre, PA 18840, USA
Am J Cardiol 94:421-6. 2004..Rather, patients' clinical risk score is the overriding determinant of clinical outcomes. Our findings emphasize the power of a well-organized high-volume system to minimize the impact of operator factors on outcomes of PCI...
Comparison of long-term outcomes of bare metal or drug-eluting stent implantation in standard versus off-label coronary narrowingsKishore J Harjai
Guthrie Clinic, Sayre, Pennsylvania, USA
Am J Cardiol 103:1537-45. 2009..In conclusion, compared with BMS, use of DES is associated with clinical benefit in standard and off-label lesions at late follow-up. Decrease in elective TVR does not explain the apparent mortality benefit from DES implantation...
Contemporary management of carotid artery stenosis: no resting places, no plateausKishore J Harjai
Guthrie Health System, Sayre, PA 18840, USA
J Interv Cardiol 19:63-6. 2006
Does proximal location of culprit lesion confer worse prognosis in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction?Kishore J Harjai
Guthrie Clinic, Sayre, Pennsylvania 18840, USA
J Interv Cardiol 19:285-94. 2006..In conclusion, proximal location of the culprit lesion is a strong independent predictor of worse in-hospital outcomes in patients with STEMI undergoing primary PCI...
Clinical outcomes following drug-eluting versus bare metal stent implantation for lesion subsets excluded from pivotal clinical trials: findings from the GHOST Study (Guthrie Health System Off-Label StenT Study)Kishore J Harjai
Guthrie Clinic, One Guthrie Square, Sayre, Pennsylvania 18840, USA
J Interv Cardiol 21:315-24. 2008..We assessed outcomes of patients undergoing drug-eluting stent (DES) vs. bare metal stent (BMS) implantation for complex lesions excluded from pivotal clinical trials of DES...
Trials and tribulations of carotid artery stenting: The Interventionalists' perspective on SAPPHIRE, EVA-3S, and SPACE TrialsKishore J Harjai
Guthrie Clinic, Sayre, PA 18840, USA
J Interv Cardiol 20:389-94. 2007....
A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading systemKishore J Harjai
Guthrie Clinic, Sayre, Pennsylvania, USA
Am J Cardiol 101:812-9. 2008..5 mg/dl consistently predicted adverse events after PCI. By unifying these 2 definitions, we devised a novel nephropathy grading system that is predictive of 6-month MACEs and all-cause mortality after PCI...
Management of multivessel coronary disease: let us not shortchange drug-eluting stentsKishore J Harjai
Cardiac Catheterization Laboratories, Guthrie Clinic, One Guthrie Square, Sayre, PA 18840, USA
J Interv Cardiol 21:213-7. 2008..Till randomized trial data become available, physicians should continue to use their clinical judgment based on existing evidence in managing their patients with multivessel coronary artery disease (CAD)...
Dual antiplatelet therapy for more than 12 months after percutaneous coronary intervention: insights from the Guthrie PCI RegistryK J Harjai
Guthrie Health System, Sayre, Pennsylvania 18840, USA
Heart 95:1579-86. 2009..To assess the impact of dual antiplatelet (DAP) therapy of >12 months on long-term death and myocardial infarction (MI) after percutaneous coronary intervention (PCI). Design, setting and..
Major adverse noncardiac events after PCI as predictors of long-term mortalityKishore Harjai
Guthrie Clinic, One Guthrie Square, Sayre, PA 18840, USA
J Interv Cardiol 21:395-402. 2008..MANE, such as post-PCI bleeding and contrast nephropathy, adversely influence survival, but are not recognized as a standard composite of complications. We assessed the feasibility and prognostic utility of deriving a composite of MANE...
Clinical outcomes in patients with the concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention: an analysis from the Guthrie Health Off-Label Stent (GHOST) investigatorsKishore J Harjai
Cardiac and Vascular Center of Excellence, Guthrie Health, 1 Guthrie Sq, Sayre, PA 18840, USA
Circ Cardiovasc Interv 4:162-70. 2011..We sought to evaluate whether the use of PPIs with clopidogrel was associated with worse clinical outcomes after percutaneous coronary intervention (PCI) compared with the use of clopidogrel alone...
Low-dose versus high-dose aspirin after percutaneous coronary intervention: analysis from the guthrie health off-label StenT (GHOST) registryKishore J Harjai
Guthrie Clinic, Sayre, Pennsylvania William Beaumont Hospital, Royal Oak, Michigan
J Interv Cardiol 24:307-14. 2011..The optimal dose of aspirin therapy after percutaneous coronary intervention (PCI) remains unclear. We sought to compare the effectiveness and safety of low and high doses of aspirin in preventing adverse outcomes after PCI...
Hemodynamic support using the Impella 2.5 catheter system during high-risk percutaneous coronary intervention in a patient with severe aortic stenosisKishore J Harjai
Guthrie Health System, Sayre, Pennsylvania 18840, USA
J Interv Cardiol 23:66-9. 2010..We describe a case of severe aortic stenosis with an estimated valve area of 0.9 cm(2) and severe ischemic cardiomyopathy in whom the Impella catheter was successfully used for high-risk multivessel percutaneous coronary intervention...
Repair of right carotid artery pseudoaneurysm in a patient with hostile aortic arch through left ventricular approachKishore J Harjai
Cardiac Catheterization Laboratories, Guthrie Clinic, One Guthrie Square, Sayre, PA 18840, USA
J Interv Cardiol 21:239-41. 2008..Our case provides proof-of-principle that complex carotid interventions can be performed expediently through a left ventricular approach in patients with hostile aortic arch...
Occurrence, predictors, and outcomes of post-percutaneous coronary intervention thrombocytopenia in an unselected populationChetan Shenoy
From the Guthrie Clinic, Sayre, Pennsylvania, USA
J Interv Cardiol 22:156-62. 2009..Background: Thrombocytopenia after PCI has been shown to portend worse prognosis in clinical trials. The significance of post-PCI thrombocytopenia has not previously been examined outside the clinical trial setting...
Effects of prior beta-blocker therapy on clinical outcomes after primary coronary angioplasty for acute myocardial infarctionKishore J Harjai
William Beaumont Hospital, Royal, Oak, Michigan 48703, USA
Am J Cardiol 91:655-60. 2003..72; 95% confidence interval 0.47 to 1.08; p = 0.11). Thus, pretreatment with beta blockers has an independent beneficial effect on short-term clinical outcomes in patients undergoing primary angioplasty for acute myocardial infarction...
Comparison of effectiveness of primary angioplasty for proximal versus distal right coronary artery culprit lesion during acute myocardial infarctionKishore J Harjai
William Beaumont Hospital, Royal Oak, Michigan 48073, USA
Am J Cardiol 90:1193-7. 2002..Thus, in patients with acute myocardial infarction referred for primary angioplasty, proximal RCA location of the culprit lesion is associated with excellent clinical outcomes that are similar to nonproximal RCA lesions...
Drug-eluting stents vs. coronary-artery bypass graftingKishore J Harjai
N Engl J Med 358:2642-3; author reply 2643-4. 2008
Prediction of one-year mortality among 30-day survivors after primary percutaneous coronary interventionsRajendra H Mehta
Duke Clinical Research Institute, Durham, North Carolina, USA
Am J Cardiol 97:817-22. 2006....
Percutaneous coronary interventions in octogenarians. glycoprotein IIb/IIIa receptor inhibitors' safety profileH Mehrdad Sadeghi
Division of Cardiology, William Beaumont Hospital, Royal Oak, Michigan 48073, USA
J Am Coll Cardiol 42:428-32. 2003....
Comparison of coronary stenting versus conventional balloon angioplasty on five-year mortality in patients with acute myocardial infarction undergoing primary percutaneous coronary interventionRajendra H Mehta
Duke Clinical Research Institute, Durham, North Carolina, USA
Am J Cardiol 96:901-6. 2005..These data support the routine use of coronary stenting in most patients undergoing primary PCI, when feasible...
Stenting of anomalous left carotid artery using a radial artery approachKishore J Harjai
Division of Cardiology, William Beaumont Hospital, Royal Oak, Michigan
Catheter Cardiovasc Interv 61:286-8. 2004..A previous attempt at selective cannulation of the left carotid artery was unsuccessful using a transfemoral approach. We performed successful carotid artery angioplasty and stenting using a right radial artery approach...
Characteristics of cerebrovascular accidents after percutaneous coronary interventionsSrinivas Dukkipati
Division of Cardiology, William Beaumont Hospital, Royal Oak, Michigan 48073, USA
J Am Coll Cardiol 43:1161-7. 2004..73, 95% CI 1.01 to 13.8; p = 0.049) after PCI. CONCLUSIONS: Cerebrovascular accidents after PCI, although rare, are associated with high rates of in-hospital death and acute renal failure, often requiring dialysis...
Clinical and angiographic correlates and outcomes of suboptimal coronary flow inpatients with acute myocardial infarction undergoing primary percutaneous coronary interventionRajendra H Mehta
University of Michigan, Ann Arbor, Michigan, USA
J Am Coll Cardiol 42:1739-46. 2003..The clustering of final TIMI < or =2 flow in high-risk groups may partially explain the poor prognosis of these patients. Awareness of these risk factors may be useful to clinicians to triage and treat patients undergoing primary PCI...
The incidence, predictors, and outcomes of early reinfarction after primary angioplasty for acute myocardial infarctionSteven J Kernis
Cardiology Division, William Beaumont Hospital, Royal Oak, Michigan, USA
J Am Coll Cardiol 42:1173-7. 2003..Admission Killip class >1 and left ventricular systolic dysfunction were associated with higher incidence of RE-MI. Our results suggest that optimal revascularization during primary PCI may decrease RE-MI rates...
Impact of nephropathy after percutaneous coronary intervention and a method for risk stratificationBeth A Bartholomew
Division of Cardiology, William Beaumont Hospital, Royal Oak, Michigan 48073, USA
Am J Cardiol 93:1515-9. 2004..The RCIN risk score was a clinical assessment tool with excellent predictive ability in identifying the larger population at risk for nephropathy in whom preventative strategies are indicated...
Frequency, determinants, and clinical implications of residual intracoronary thrombus following primary angioplasty for acute myocardial infarctionKishore J Harjai
William Beaumont Hospital, Royal Oak, Michigan 48703, USA
Am J Cardiol 92:377-82. 2003..However, differences in outcomes between patients with and without residual thombus are related to baseline clinical differences rather than thrombus per se...
Ischemia-driven target vessel revascularization after-primary percutaneous coronary intervention: patients at risk and their outcomesRajendra H Mehta
Duke Clinical Research Institute, Durham, North Carolina, USA
J Interv Cardiol 18:149-54. 2005..Importantly, our data suggest that no increase in mortality occur, if ITVR is promptly performed to treat recurrent ischemia after primary PCI...
Prognostic significance of transient no-reflow during primary percutaneous coronary intervention for ST-elevation acute myocardial infarctionRajendra H Mehta
University of Michigan, Ann Arbor, Michigan, USA
Am J Cardiol 92:1445-7. 2003..04) and 6-month mortality (3% vs 31%, adjusted odds ratio 5.4, 95% confidence interval 1.01 to 29.0, p=0.0001)...
Comparison of outcomes of diabetic and nondiabetic patients undergoing primary angioplasty for acute myocardial infarctionKishore J Harjai
William Beaumont Hospital, Royal Oak, Michigan, USA
Am J Cardiol 91:1041-5. 2003..We conclude that diabetics with AMI have less favorable baseline characteristics and are less likely to undergo primary PCI than nondiabetics. Despite excellent angiographic results, diabetics had significantly worse 6-month mortality...
Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty?Steven J Kernis
Cardiology Division, William Beaumont Hospital, Royal Oak, Michigan 48331, USA
J Am Coll Cardiol 43:1773-9. 2004..We sought to determine if beta-blocker therapy improves clinical outcomes of acute myocardial infarction (AMI) after successful primary percutaneous coronary intervention (PCI)...
The relationship between left ventricular shape and QT interval dispersionKishore J Harjai
Ochsner Clinic, New Orleans, Louisiana, USA
Echocardiography 19:641-4. 2002....
Suboptimal inhibition of platelet aggregation following tirofiban bolus in patients undergoing percutaneous coronary intervention for unstable angina pectorisDaniel Soffer
Division of Cardiology, William Beaumont Hospital, Royal Oak, Michigan 48073, USA
Am J Cardiol 91:872-5. 2003
Use of aspirin in conjunction with angiotensin-converting enzyme inhibitors does not worsen long-term survival in heart failureKishore J Harjai
Department of Cardiology, Ochsner Clinic, New Orleans, USA
Int J Cardiol 88:207-14. 2003..We explored the effect of combined ACE-I and aspirin therapy compared to ACE-I without aspirin on clinical outcomes in patients with heart failure...
Impact of angina class on inhibition of platelet aggregation following clopidogrel loading in patients undergoing coronary intervention: do we need more aggressive dosing regimens in unstable angina?Daniel Soffer
Division of Cardiology, William Beaumont Hospital, Royal Oak, Michigan 48073, USA
Catheter Cardiovasc Interv 59:21-5. 2003..018). Patients with UA undergoing PCI have a lower IPA following clopidogrel loading with 450 mg. This may indicate the possibility of clopidogrel resistance in such patients...
Variation in hospital length of stay in patients with acute myocardial infarction undergoing primary angioplasty and the need to change the diagnostic-related group systemBeth A Bartholomew
William Beaumont Hospital, Royal Oak, Michigan 48073, USA
Am J Cardiol 92:830-3. 2003..Our investigation suggests the need for a multi-tier diagnostic-related group system for patients with acute myocardial infarction treated with percutaneous coronary intervention...
Sustained ventricular tachycardia or fibrillation in the cardiac catheterization laboratory among patients receiving primary percutaneous coronary intervention: incidence, predictors, and outcomesRajendra H Mehta
University of Michigan, Ann Arbor, Michigan, USA
J Am Coll Cardiol 43:1765-72. 2004..Our data further help identify patients at risk of VT/VF during primary PCI and suggest that pretreatment with beta-blockers should be strongly considered to reduce these arrhythmias...
Procedural success versus clinical risk status in determining discharge of patients after primary angioplasty for acute myocardial infarctionPrabhakara S Heggunje
William Beaumont Hospital, Royal Oak, Michigan 48073-6769, USA
J Am Coll Cardiol 44:1400-7. 2004..In contrast, patients with more than two high-risk clinical features or unsuccessful PCI may need longer observation...
Left ventricular remodeling and systolic deterioration in acute myocardial infarction: findings from the Stent-PAMI StudyStephen J Mattichak
William Beaumont Hospital, Royal Oak, MI 48073, USA
J Interv Cardiol 18:255-60. 2005..We sought to determine predictors of LVSD by comparing demographic, procedural, angiographic variables, and 6-month major adverse cardiac events (MACE) in patients with and without LVSD after MI...
Does racial bias exist in the medical management of heart failure?Kishore J Harjai
Department of Cardiology, Ochsner Clinic, New Orleans, Louisiana, USA
Clin Cardiol 25:479-83. 2002..It is suspected that effective therapies are often underutilized in black compared with white patients with coronary artery disease (CAD)...
